A5063566691- Acute Ischemic Stroke Management
- Blood Pressure and Hypertension Studies
- Stroke Rehabilitation and Recovery
- Cerebrovascular and Carotid Artery Diseases
- Neurological Disorders and Treatments
Sergiyev Posad Humanitarian Institute
2022
Thrombolytic therapy (TLT) of ischemic stroke (IS) with alteplase within the first 4.5 hours from onset symptoms is most effective and proven method treatment. Objective: to evaluate safety efficacy TLT Revelisa (alteplase) in IS real-world clinical practice. Material methods. The results were analyzed 1181 patients IS: 616 (52.2%) women 565 (47.8%) men (mean age 68.28±12.56 years), which 140 (11.9%) staged reperfusion. mean time disease was 2.58±0.83 hours. Heidelberg classification used...
Evaluation of the safety and effectiveness thrombolytic therapy (TLT) with drug Revelisa (alteplase) in patients ischemic stroke (AI) real clinical practice.An open prospective multicenter non-interventional register study was conducted, which included 550 AI - 259 (47.1%) women 291 (52.9%) men; average age 67.7±12.6 years. All underwent TLT within 4.5 hours from onset disease and, according to protocol reperfusion AI, clinical, instrumental laboratory examinations were performed....